standard IOT/mortalité J28
dependent_2="IOT_mortalite_J28"
dependent_1="Oxy_cov$IOT_mortalite_J28_O.N"
explanatory_general=c("Age","sexe","IMC","IMC_inf_30","IMC_sup_30","Vaccination","ATCD_Diabète ","ATCD_HTA","ATCD_ID","ATCD_Path_respi","ATCD_Cardiopathie","ATCD_IR_Dialyse","TDM_Severite_majeure","TDM_Severite_severe","TDM_Severite_moderee","TDM_Severite_minime","TA_Tocilizumab","TA_plasma_conv","ATC")
explanatory_2=c("Age","sexe","IMC","IMC_inf_30","IMC_sup_30","Vaccination","ATCD_Diabète ","ATCD_HTA","ATCD_ID","ATCD_Path_respi","ATCD_Cardiopathie","TDM_Severite_severe","TDM_Severite_moderee","TDM_Severite_minime","TA_Tocilizumab","TA_plasma_conv","ATC")
res_glm_uni_general <- Oxy_cov%>%
glmuni(dependent_1, explanatory_general) %>%
fit2df(estimate_suffix=" (univarié)")
kable(res_glm_uni_general,row.names=FALSE, align=c("l", "l", "r", "r", "r", "r"))
| Age |
1.02 (1.00-1.06, p=0.115) |
| sexeM |
0.78 (0.36-1.73, p=0.529) |
| IMCIMC<30 |
0.79 (0.11-16.00, p=0.838) |
| IMCIMC>30 |
1.71 (0.23-34.79, p=0.640) |
| IMC_inf_30Non |
1.71 (0.23-34.79, p=0.640) |
| IMC_inf_30Oui |
0.79 (0.11-16.00, p=0.838) |
| IMC_sup_30Non |
0.79 (0.11-16.00, p=0.838) |
| IMC_sup_30Oui |
1.71 (0.23-34.79, p=0.640) |
| VaccinationOui |
0.90 (0.13-3.81, p=0.899) |
| ATCD_DiabèteOui |
1.41 (0.59-3.23, p=0.421) |
| ATCD_HTAOui |
1.61 (0.76-3.44, p=0.218) |
| ATCD_IDOui |
3.15 (0.74-12.59, p=0.101) |
| ATCD_Path_respiOui |
2.42 (0.97-5.82, p=0.051) |
| ATCD_CardiopathieOui |
1.18 (0.40-3.07, p=0.752) |
| ATCD_IR_DialyseOui |
1.22 (0.06-9.84, p=0.868) |
| TDM_Severite_majeureOui |
6.89 (1.60-35.11, p=0.011) |
| TDM_Severite_severeOui |
1.13 (0.50-2.47, p=0.754) |
| TDM_Severite_modereeOui |
0.62 (0.28-1.31, p=0.212) |
| TDM_Severite_minimeOui |
0.78 (0.21-2.28, p=0.675) |
| TA_TocilizumabOui |
1.19 (0.50-2.68, p=0.687) |
| TA_plasma_convOui |
1.22 (0.06-9.84, p=0.868) |
| ATCATC_P |
0.24 (0.07-0.82, p=0.020) |